Previous 10 | Next 10 |
home / stock / ecl / ecl articles
Hawkins, Inc. (NASDAQ: HWKN) has completed the acquisition of the assets of Intercoastal Trading, Inc. and its affiliates. Intercoastal Trading sup...
Nucor Corporation (NYSE: NUE) announced an agreement to acquire Rytec Corporation, a leading manufacturer and seller of high-speed, high-performanc...
Inari Medical (NASDAQ: NARI) continues to ride on the success of its ClotTriever and FlowTriever products available for treating venous thromboembo...
Intuitive Surgical (NASDAQ: ISRG) witnessed strong momentum in the year-to-date period. Shares of the company have gained 20% compared with 8....
Incisive investors should look out for breakout stocks to get unmatched returns. However, stocks mostly trade within a narrow range during the summ...
DaVita (NYSE: DVA) witnessed strong momentum year to date. Shares of the company rallied 34.5% compared with 11.2% growth of the industry...
Dow Inc. (NYSE: DOW) recently announced the start-up of propylene glycol capacity increase at its integrated manufacturing facility at Map Ta ...
Eastman Chemical Company (NYSE: EMN), which produces Naia cellulosic fibers, has formed a strategic partnership with Debrand, a well-known next-lif...
Ecolab (NYSE:ECL) has outperformed the market over the past 20 years by 2.71% on an annualized basis producing an average annual return of 10.75%. ...
News, Short Squeeze, Breakout and More Instantly...
DELRAY BEACH, Fla., July 17, 2024 (GLOBE NEWSWIRE) -- BioProcess360 Partners today announced the launch of a new investment fund to support businesses with the growth of emerging tools and technologies used in the bioprocessing of traditional mAbs and newer drug modalities. BioProcess360 Partners...
Ecolab Inc. (NYSE: ECL) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 2.2% on the day to $243.43. Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internatio...
2024-07-08 06:00:05 ET Shlomo Rosenbaum from Stifel Nicolaus issued a price target of $283.00 for ECL on 2024-07-08 05:06:00. The adjusted price target was set to $283.00. At the time of the announcement, ECL was trading at $238.19. The overall price target consensus is ...